Back
ESC Premium Access

The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population

Session: Pharmacology and Pharmacotherapy ePosters
Topic: Lipid-Lowering Agents
Speaker: Doctor D. Radenkovic (London, GB)
Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Dina Radenkovic

Guy's and St Thomas' Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

56 more presentations in this session

Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects

Speaker: Professor Y. Huo (Beijing, CN)

Access
Abstract
Slides
Thumbnail

Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects

Speaker: Doctor C. Becker (Wuppertal, DE)

Access
Abstract
Slides
Thumbnail

Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics

Speaker: Doctor S. Frechen (Leverkusen, DE)

Access
Abstract
Slides
Thumbnail

Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study

Speaker: Doctor C. Ballantyne (Houston, US)

Access
Abstract
Slides
Thumbnail

Adherence to high-intensity statin therapy after acute coronary syndrome and its impact on patient outcome

Speaker: Doctor P. Sulzgruber (Vienna, AT)

Access
Abstract
Slides
Thumbnail

Access the full session

Pharmacology and Pharmacotherapy ePosters

Speakers: Doctor D. Radenkovic, Professor Y. Huo, Doctor C. Becker, Doctor S. Frechen, Doctor C. Ballantyne...
Access
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb